top of page

LGMD2L refers to the condition also called LGMDR12 under a revised naming system developed to standardize muscular dystrophy classification. Learn more
LGMD2L is a rare genetic disorder affecting up to 1 in 60,000 people worldwide.
The disease causes progressive muscle weakness making daily activities difficult.
There is no cure for LGMD2L but research is uncovering potential treatments.
We’re advancing research for LGMD2L
Through strategic funding, expert collaboration, and innovative research, we’re working to support those affected by LGMD2L and drive progress toward a cure.

Why do we fund research?
LGMD2L is under-researched, making progress towards treatments slow. By funding foundational research, we aim to bridge this gap for both researchers and patients.

How do we fund research?
Our funding focuses on collaboration with experts in academia, public, and private sectors to drive breakthroughs in LGMD2L research.
© 2025 LGMD2L Foundation. All rights reserved.
bottom of page